313 related articles for article (PubMed ID: 27261830)
1. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
Skibsbye L; Ravens U
Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
[TBL] [Abstract][Full Text] [Related]
2. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Schmitt N; Grunnet M; Olesen SP
Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
[TBL] [Abstract][Full Text] [Related]
3. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk.
Furutani K
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003453
[TBL] [Abstract][Full Text] [Related]
5. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis.
Chay TR
J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
Larsen AP; Olesen SP; Grunnet M; Poelzing S
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
[TBL] [Abstract][Full Text] [Related]
7. Atrial-selective K
Ravens U
Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
[TBL] [Abstract][Full Text] [Related]
9. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
11. Blockers of the slowly delayed rectifier potassium IKs channel: potential antiarrhythmic agents.
Gerlach U
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):243-52. PubMed ID: 15326915
[TBL] [Abstract][Full Text] [Related]
12. Modernized Classification of Cardiac Antiarrhythmic Drugs.
Lei M; Wu L; Terrar DA; Huang CL
Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
[TBL] [Abstract][Full Text] [Related]
13. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
Brendel J; Peukert S
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):273-87. PubMed ID: 15326917
[TBL] [Abstract][Full Text] [Related]
14. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
15. Atrial selectivity of antiarrhythmic drugs.
Ravens U; Poulet C; Wettwer E; Knaut M
J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
[TBL] [Abstract][Full Text] [Related]
16. Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.
McCauley M; Vallabhajosyula S; Darbar D
Card Electrophysiol Clin; 2016 Jun; 8(2):481-93. PubMed ID: 27261836
[TBL] [Abstract][Full Text] [Related]
17. IKr channel blockers: novel antiarrhythmic agents.
Lee K; Park JY; Ryu PD; Kwon LS; Kim HY
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):203-23. PubMed ID: 15326913
[TBL] [Abstract][Full Text] [Related]
18. [Potassium channels and arrhythmia].
Funck-Brentano C
Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
[TBL] [Abstract][Full Text] [Related]
20. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
Grunnet M; Bentzen BH; Sørensen US; Diness JG
Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
